Pharma-Bio Serv (PBSV) Accumulated Depreciation & Amortization (2016 - 2025)
Pharma-Bio Serv (PBSV) has disclosed Accumulated Depreciation & Amortization for 14 consecutive years, with $199929.0 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization fell 69.63% year-over-year to $199929.0, compared with a TTM value of $199929.0 through Oct 2025, down 69.63%, and an annual FY2025 reading of $199929.0, down 69.63% over the prior year.
- Accumulated Depreciation & Amortization was $199929.0 for Q4 2025 at Pharma-Bio Serv, down from $658249.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $658249.0 in Q4 2024 and bottomed at $199929.0 in Q4 2025.
- Average Accumulated Depreciation & Amortization over 5 years is $523732.0, with a median of $587089.0 recorded in 2022.
- The sharpest move saw Accumulated Depreciation & Amortization increased 9.05% in 2022, then crashed 69.63% in 2025.
- Year by year, Accumulated Depreciation & Amortization stood at $538384.0 in 2021, then grew by 9.05% to $587089.0 in 2022, then grew by 8.16% to $635009.0 in 2023, then grew by 3.66% to $658249.0 in 2024, then plummeted by 69.63% to $199929.0 in 2025.
- Business Quant data shows Accumulated Depreciation & Amortization for PBSV at $199929.0 in Q4 2025, $658249.0 in Q4 2024, and $635009.0 in Q4 2023.